Moderna
MRNA
MRNA
1,107 hedge funds and large institutions have $62B invested in Moderna in 2021 Q4 according to their latest regulatory filings, with 221 funds opening new positions, 402 increasing their positions, 378 reducing their positions, and 232 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
25% less call options, than puts
Call options by funds: $5.69B | Put options by funds: $7.59B
34% less capital invested
Capital invested by funds: $93.5B → $62B (-$31.5B)
44% less funds holding in top 10
Funds holding in top 10: 39 → 22 (-17)
Holders
1,107
Holding in Top 10
22
Calls
$5.69B
Puts
$7.59B
Top Buyers
| 1 | +$1.04B | |
| 2 | +$599M | |
| 3 | +$311M | |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$276M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$267M |
Top Sellers
| 1 | -$1.28B | |
| 2 | -$924M | |
| 3 | -$515M | |
| 4 |
Morgan Stanley
New York
|
-$240M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$215M |